The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.
StockStory.org on MSN9h
Why Solventum (SOLV) Stock Is Down TodayWhat Happened? Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the ...
Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory ...
Wells Fargo raised the firm’s price target on Solventum (SOLV) to $75 from $73 and keeps an Equal Weight rating on the shares. The Q4 beat was ...
Piper Sandler raised the firm’s price target on Solventum (SOLV) to $84 from $75 and keeps a Neutral rating on the shares. The firm notes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback